论文部分内容阅读
目的:研究罗红霉素缓释片联合丹参片治疗精囊炎的疗效及安全性。方法:将本院2010年1月~2014年5月门诊收治的92例精囊炎患者完全随机分为对照组和试验组,每组各46例。试验组口服罗红霉素缓释片联合丹参片,对照组口服罗红霉素缓释片,共4周。4周后通过尿常规、前列腺液常规、精液常规及细菌培养结果、慢性前列腺症状评分以及生活质量评分等观察指标来评估疗效。结果:试验组相对于对照组治疗后的前列腺液常规、精液常规、慢性前列腺症状评分以及生活质量评分和对照组相比差异有统计学意义(P<0.05),尿常规结果差异无统计学(P>0.05)。结论:罗红霉素缓释片联合丹参片治疗精囊炎的可以有效缓解症状,安全可靠,效果确切。
Objective: To study the efficacy and safety of roxithromycin sustained-release tablets and Danshen tablets in the treatment of seminal vesiculitis. Methods: 92 patients with vesiculitis admitted to our hospital from January 2010 to May 2014 were randomly divided into control group and experimental group, with 46 cases in each group. The experimental group oral roxithromycin sustained-release tablets combined with Salvia tablets, the control group oral roxithromycin tablets, a total of 4 weeks. After 4 weeks, the curative effect was evaluated by urine routine, routine prostatic fluid, routine and bacterial culture of semen, chronic prostate symptom score and quality of life scores. Results: There was significant difference between the experimental group and the control group (P <0.05), and there was no significant difference in the results of routine urine test (P> 0.05) between the routine prostatic fluid and routine semen, chronic prostate symptom scores and quality of life scores P> 0.05). Conclusion: Roxithromycin sustained-release tablets combined with Danshen tablets in the treatment of seminal vesiculitis can effectively relieve the symptoms, which is safe, reliable and effective.